Laminin 332 maintains CSC characteristics and EMT phenotype in lung cancer; supports stemness of human hepatic CSCs by promoting quiescence, chemoresistance, the number of side population, and in vivo tumor growth in a mTORC2-dependent manner. Here, LAMB2 is linked to lung carcinoma.